| Delicious |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Home and Family > Pregnancy > Fetal Circulation and Transition To Extra-Uterine Life |
|
Delicious - Fetal Circulation and Transition To Extra-Uterine Life
The development of a human baby from a single cell (one ovum unites with one sperm to form the zygote, the name given to fertilized ovum) and the subsequent transition from intra-uterine to extra uterine life is one of the greatest wonders of creation. It is to be remembered that the fetus cannot get a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product tmospheric oxygen but is nourished by oxygen from the mother through the placenta. In order to achieve this, the fetus has a mechanism which would be highly abnormal in extra uterine life. To understand this, first we need to understand the normal circulation in adults. The heart is a four chambered organ. T ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in he two upper chambers are called atria-left and right. The two lower ones are called ventricles –left and right. The 2 atria are completely separated by a structure called inter-atrial septum. Similarly the ventricles are separated by the inter-ventricular septum. Thus blood in the left side of the heart is c lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ompletely separated from the blood in the right side. The right atrium receives blood from all the organ of the body through two main blood vessels-the superior vena cava and the inferior vena cava and then pumps that blood into the right ventricle. This blood is depleted of oxygen. The right ventricle here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe pumps this blood into the lungs through a blood vessel called pulmonary artery, which divides into two one each for a lung. The main artery goes on dividing and subdividing till it reaches the sac like structures in the lungs called alveoli. The total surface area of alveoli is roughly equal to the size of a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tennis court. In the alveoli gas exchange takes place-carbon-dioxide is thrown out and oxygen is taken up by the blood. The minute blood vessels carry oxygenated blood into progressively larger blood vessels and ultimately this blood comes to the left atrium through four pulmonary veins. From the left ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc atrium oxygenated blood enters the left ventricle through the left atrio-ventricular valve. The left ventricle then pumps blood into a big blood vessel called aorta. This gives off branches and supplies oxygenated blood to all the cells of the body-the whole process is no less complicated than the water supp easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ly and drainage system of a town! Blood from the cells is again returned to the right atrium thus completing the cycle. The cycle goes on and on till the end of life. This can never work in a fetus because there is no direct access to atmospheric oxygen. Nature has devised a wonderful mechanism to supply oxy nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically gen to the fetus. The umbilical cord which forms the link between the mother and the fetus and is cut after birth, contains a blood vessel called umbilical vein. This vein carries oxygenated blood from the placenta into fetus. This divides into two inside the body of the fetus one branch goes to the liver and and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the other called ductus venosus joins inferior vena cava, which carries deoxygenated blood to the right atrium. From this point the fetal circulation is different. As this oxygenated blood has to be supplied to all the fetal cells it has to go to the left side of the heart. There is no point in pumping it ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi o lungs, which cannot carry out gas exchange. The inter-atrial septum in the fetus consists of two overlapping layers. They overlap in such a way that blood from the right atrium can enter the left atrium but the reverse cannot take place (valve like mechanism). The pressure in the right side heart in the fet ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a us is higher than the left-exactly opposite to that after birth. Hence most of this blood goes into the left atrium, then to the left ventricle and pumped into aorta. The right atrium also receives deoxygenated blood from the upper parts of the body through the superior vena cava. This blood mixes with blood dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod from the inferior vena cava (which carries blood with higher oxygen concentration) enters the right ventricle and then pumped into the pulmonary artery. In the fetus the pulmonary artery is connected to the aorta by a blood vessel called ductus arteriosus. Because there is no point in pumping blood into the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin lungs most of the blood in the pulmonary artery in shunted across the ductus arteriosus into the aorta. This blood contains less oxygen than that pumped by the left ventricle and supplies the lower parts of the body. The umbilical cord also contains two umbilical arteries. These arteries contain deoxygen tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ated blood from the fetus into the placenta completing the cycle. Soon after birth the umbilical cord is clamped and cut. This increases resistance to systemic blood flow and raises the pressure in the left side of the heart. At the same time pulmonary pressure falls as air enters the lungs of the baby with t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the first breath. This stops the right to left shunting of blood across the atria. As the pressure in the aorta goes above that of pulmonary artery the shunt across ductus arteriosus gets reversed and some blood flows from the aorta into the pulmonary artery. But the ductus arteriosus starts shrinking and fun ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ctionally closes by about 72 hours of life and anatomically closes within a few weeks. Thus the mixing of blood between the two sides of the heart completely stops and the usual adult type of blood circulation is established. Another unique feature of the fetus is the presence of a different type of hemoglob y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products in called fetal hemoglobin. This differs from the adult hemoglobin in that it has higher affinity for oxygen than the adult hemoglobin. Hence it is able to take up hemoglobin from the maternal hemoglobin and deliver it to fetal cells. It can be observed that fetal cells get blood with lower concentration of o . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de xygen than adults do because of mixing of blood in the two sides of the heart. The fetus is able to survive in spite of low oxygen concentration because the maternal body takes care of many functions and the energy requirement is lower. After birth the concentration of fetal hemoglobin falls rapidly and that elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip of adult hemoglobin increases. Thus nature ensures that the fetus develops inside the uterus by getting oxygen from the mother and soon after birth starts utilizing atmospheric oxygen through a complicated mechanism. It is indeed amazing that for the vast majority of newborns the transition is smooth tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Diabetes-New Type 2 Risk Factors Identified 5 Common Nutritional Errors That Could Be Making Your Back Pain Worse!
|